[1] HANSEN C A, MILLER D R, ANNARUMMA S, et al. Levodopa-induced dyskinesia: a historical review of Parkinson’s disease, dopamine, and modern advancements in research and treatment[J]. J Neurol, 2022, 269(6): 2892-2909. [2] RUONALA V, PEKKONEN E, AIRAKSINEN O, et al. Levodopa-induced changes in electromyographic patterns in patients with advanced Parkinson’s disease[J]. Front Neurol, 2018, 9: 35. [3] SIVANANDY P, LEEY T C, XIANG T C, et al. Systematic review on Parkinson’s disease medications, emphasizing on three recently approved drugs to control Parkinson’s symptoms[J]. Int J Environ Res Public Health, 2021, 19(1): 364. [4] SUKHANOV I, DOROTENKO A, FESENKO Z, et al. Inhibition of PDE10A in a new rat model of severe dopamine depletion suggests new approach to non-dopamine Parkinson’s disease therapy[J]. Biomolecules, 2022, 13(1): 9. [5] SCHMIDT F A, MARTINEZ-TORRES I, GERMANN J, et al. Disparities in access to deep brain stimulation[J]. Stereotact Funct Neurosurg, 2026, 104(2):101-107. [6] LU Q Q, ZHU P A, LI Z L, et al. Efficacy of repetitive transcranial magnetic stimulation over the supplementary motor area on motor function in Parkinson’s disease: a meta-analysis[J]. Am J Phys Med Rehabil, 2025, 104(4): 318-324. [7] ZHANG H L, JIN R J, GUAN L, et al. Extracorporeal shock wave therapy on spasticity after upper motor neuron injury: a systematic review and meta-analysis[J]. Am J Phys Med Rehabil, 2022, 101(7): 615-623. [8] LUO S, GOETZ C G, CHOI D, et al. Resolving missing data from the movement disorder society unified Parkinson’s disease rating scale: implications for telemedicine[J]. Mov Disord, 2022, 37(8): 1749-1755. [9] MIRABELLA G, PILOTTO A, RIZZARDI A, et al. Effects of dopaminergic treatment on inhibitory control differ across Hoehn and Yahr stages of Parkinson’s disease[J]. Brain Commun, 2024, 6(1): fcad350. [10] BEARD J, WILLIAMS G, KAHN M, et al. The Modified Ashworth and Modified Tardieu Scales differ in their classification of lower limb spasticity[J]. Clin Rehabil, 2025, 39(6): 2692155251337306. [11] PRAMUAN P, ASAWABHARUJ J, SIRIPHORN A. Comparative accuracy of the figure-of-eight walk test and 10-meter walk test in classifying walking abilities in stroke survivors[J]. J Bodyw Mov Ther, 2025, 45: 1106-1111. [12] MANCA A, CEREATTI A, BAR-ON L, et al. A survey on the use and barriers of surface electromyography in neurorehabilitation[J]. Front Neurol, 2020, 11: 573616. [13] 齐文亮, 陈蒙, 王宇航, 等. 表面肌电图对青年卒中患者偏瘫步态的评价作用[J]. 中国现代神经疾病杂志, 2025, 25(8): 717-724. [14] 向云, 刘家庆. 表面肌电评定脑卒中后肢体痉挛状态的meta分析[J]. 中国康复医学杂志, 2019, 34(8): 960-965. [15] AMATACHAYA S, NAEWLA S, SRISIM K, et al. Concurrent validity of the 10-meter walk test as compared with the 6-minute walk test in patients with spinal cord injury at various levels of ability[J]. Spinal Cord, 2014, 52(4): 333-336. [16] AYVAT F, AYVAT E, DOGÄN M, et al. Can Timed Up and Go Test discriminate the risk of falling in patients with Multiple Sclerosis with low to moderate impairment?[J]. Disabil Rehabil, 2025, 47(12): 3189-3194. [17] HONEINE J L, SCHIEPPATI M, GAGEY O, et al. The functional role of the triceps surae muscle during human locomotion[J]. PLoS One, 2013, 8(1): e52943. [18] VIALLERON T, DELAFONTAINE A, MILLERIOUX I, et al. Acute effects of short-term stretching of the triceps surae on ankle mobility and gait initiation in patients with Parkinson’s disease[J]. Clin Biomech: Bristol, 2021, 89: 105449. [19] MCKAY J L, HACKNEY M E, FACTOR S A, et al. Lower limb rigidity is associated with frequent falls in Parkinson’s disease[J]. Mov Disord Clin Pract, 2019, 6(6): 446-451. [20] MIHAI E E, DUMITRU L, MIHAI I V, et al. Long-term efficacy of extracorporeal shock wave therapy on lower limb post-stroke spasticity: a systematic review and meta-analysis of randomized controlled trials[J]. J Clin Med, 2020, 10(1): 86. [21] DE ROO E G, KOOPMAN S B, JANSSEN T W, et al. The effects of extracorporeal shock wave therapy in children with cerebral palsy: a systematic review[J]. Int J Surg, 2025, 111(4): 2773-2790. [22] LORENTZEN J, GREY M J, CRONE C, et al. Distinguishing active from passive components of ankle plantar flexor stiffness in stroke, spinal cord injury and multiple sclerosis[J]. Clin Neurophysiol, 2010, 121(11): 1939-1951. [23] GUO J, HAI H, MA Y. Application of extracorporeal shock wave therapy in nervous system diseases: a review[J]. Front Neurol, 2022, 13: 963849. [24] LENG Y, LO W L A, HU C, et al. The effects of extracorporeal shock wave therapy on spastic muscle of the wrist joint in stroke survivors: evidence from neuromechanical analysis[J]. Front Neurosci, 2020, 14: 580762. [25] SOHN M K, CHO K H, KIM Y J, et al. Spasticity and electrophysiologic changes after extracorporeal shock wave therapy on gastrocnemius[J]. Ann Rehabil Med, 2011, 35(5): 599-604. [26] SAWAN S, ABD-ALLAH F, HEGAZY M M, et al. Effect of shock wave therapy on ankle plantar flexors spasticity in stroke patients[J]. Neuro Rehabilitation, 2017, 40(1): 115-118. [27] DIETZ V, QUINTERN J, BERGER W. Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia[J]. Brain, 1981, 104(3): 431-449. [28] ASCI F, FALLETTI M, ZAMPOGNA A, et al. Rigidity in Parkinson’s disease: evidence from biomechanical and neurophysiological measures[J]. Brain, 2023, 146(9): 3705-3718. |